Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
[Involvement of insulin and IGF-1 signaling molecules in bone metabolism] [PMID: 18445879] Laboratory literature summary: [Involvement of insulin and IGF-1 signaling molecules in bone metabolism]
Patients with obesity and metabolic syndrome : Weight reduction achieved through GLP-1 therapy often correlates with improvements in the characteristic dyslipidaemia of metabolic syndrome (elevated triglycerides, low HDL cholesterol, and small dense LDL particles)
Beyond six months, lipid improvements tend to stabilize alongside weight
No communication at all
[11] Incretins, primarily GLP-1 and gastric inhibitory polypeptide (GIP), stimulate insulin secretion in a glucose-dependent manner and modulate satiety, energy intake, and lipid metabolism
